• Return to Headlines

Relatively Good Performance Detected in Shares of Vanda Pharmaceut in the Biotechnology Industry (VNDA , MGNX , DVAX , VCYT , LGND )

By James Quinn

Below are the top five companies in the Biotechnology industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have the potential to outperform.

Vanda Pharmaceut (NASDAQ:VNDA ) ranks first with a gain of 14.72%; Macrogenics Inc (NASDAQ:MGNX ) ranks second with a gain of 9.94%; and Dynavax Technolo (NASDAQ:DVAX ) ranks third with a gain of 5.97%.

Veracyte Inc (NASDAQ:VCYT ) follows with a gain of 5.92% and Ligand Pharm (NASDAQ:LGND ) rounds out the top five with a gain of 5.04%.

SmarTrend recommended that its subscribers protect gains by selling shares of Ligand Pharm on October 8th, 2018 by issuing a Downtrend alert when the shares were trading at $250.70. Since that call, shares of Ligand Pharm have fallen 35.0%. We are now looking for when a new Uptrend will commence and will alert SmarTrend subscribers in real time.

Keywords: relative performance vanda pharmaceut macrogenics inc dynavax technolo veracyte inc ligand pharm